NCT05650125 A Platform Study for solId orgaN CancERs
| NCT ID | NCT05650125 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Liverpool |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2022-01-01 |
| Primary Completion | 2030-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2022-01-01 with a primary completion date of 2030-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Generating bespoke biosampling protocols for individual tumour specific translational projects is onerous, cumbersome and inefficient. This study aims to provide a broad platform to maximise the unique access to biopsy and resected tumour specimens available from cancer patients to provide a high-quality and efficient source of biosamples for specific translational projects. Access to historical FFPE samples and clinical data, as well as prospective fresh tissue samples, will allow interrogation of the underlying biology of these cancers. Matched pseudoanonymised clinical and radiological data will allow the development of rich high-yield datasets.
Eligibility Criteria
Inclusion Criteria: * Biopsy or surgical resection as standard of care Exclusion Criteria: * Refusal or inability to consent, paediatric patients
Frequently Asked Questions
Who can join the NCT05650125 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 100 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05650125 currently recruiting?
Yes, NCT05650125 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Liverpool to inquire about joining.
Where is the NCT05650125 trial being conducted?
This trial is being conducted at Liverpool, United Kingdom.
Who is sponsoring the NCT05650125 clinical trial?
NCT05650125 is sponsored by University of Liverpool. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.